2 completed, 1 active not recruiting, 1 enrolling by invitation, 1 not yet recruiting. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Hemanext: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypoxic Red Blood Cells in Sickle Cell Anemia Hemanext ONE System, Conventional RBCs - Sickle Cell Anaemia, Sickle Cell Anemia Crisis | Not applicable | Not yet recruiting | Hemanext | 48 | 2026-11-30 | 2026-11-02 |
| Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients Transfusion-dependent Beta-Thalassemia, Blood Transfusion | Enrolling by invitation | University Research Institute for the Study of Genetic & Malignant Disorders in Childhood | 30 | 2025-11-20 | 2025-12-17 | |
| Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion Hemanext ONE system, Conventional RBCs - Hematologic Neoplasms | Not applicable | Active not recruiting | Hemanext | 24 | 2024-11-29 | 2026-08-14 |
| Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital Hypoxic Red Blood Cells - Hematologic Neoplasms, Burns | Completed | Hemanext | 22 | 2022-08-24 | 2025-07-23 | |
| Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells Hemanext One - Whole Blood Donations and Leukoreduction | Phase 2 | Withdrawn | Hemanext | 2020-07-01 | 2020-08-03 | |
| Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial Hemanext Red Blood Cell Processing System - Whole Blood Donation and Leukoreduction | Phase 2 | Completed | Hemanext | 100 | 2017-11-27 | 2020-06-23 |
Hematologic Neoplasms (2) · Hypoxia (2) · Anemia (1) · Anemia, Sickle Cell (1) · Burns (1) · Vaso-Occlusive Crises (1)
United States (4) · Norway (2) · Greece (1)
Antonis Kattamis, Professor (1) · Biree Andemariam, MD (1) · Faye West, MD (1) · Jose A Cancelas Perez, MD, PhD (1) · Jose Cancelas, MD, PhD (1) · Laurel Omert, MD, FACS (1) · Matthew Karafin, MD (1) · Philip Howard, MD (1)